| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 452 | 10.617 | 8.407 | 37.051 | 4.930 | 2.185 | 12.145 | 10.731 |
| Total Income - EUR | - | - | 452 | 10.637 | 9.274 | 37.530 | 5.760 | 2.207 | 12.226 | 11.008 |
| Total Expenses - EUR | - | - | 132 | 347 | 7.481 | 303 | 1.364 | 959 | 3.852 | 16.927 |
| Gross Profit/Loss - EUR | - | - | 320 | 10.289 | 1.793 | 37.227 | 4.396 | 1.248 | 8.374 | -5.919 |
| Net Profit/Loss - EUR | - | - | 307 | 9.971 | 1.529 | 36.131 | 4.248 | 1.184 | 7.195 | -5.919 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Ir Hematomedical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.182 |
| Current Assets | - | - | 474 | 10.666 | 12.922 | 47.811 | 51.569 | 7.346 | 19.314 | 11.321 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 376 | 423 | 428 | 1.343 | 344 | 1.817 |
| Cash | - | - | 474 | 10.666 | 12.546 | 47.388 | 51.142 | 6.003 | 18.971 | 9.505 |
| Shareholders Funds | - | - | 351 | 10.315 | 6.401 | 42.411 | 45.719 | 1.275 | 8.466 | 2.500 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 123 | 351 | 6.521 | 5.400 | 5.850 | 6.071 | 10.848 | 12.003 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ir Hematomedical Srl